Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Revance Therapeutics (RVNC)

Revance Therapeutics (RVNC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 982,452
  • Shares Outstanding, K 45,108
  • Annual Sales, $ 3,730 K
  • Annual Income, $ -142,570 K
  • 60-Month Beta 1.23
  • Price/Sales 1,091.96
  • Price/Cash Flow N/A
  • Price/Book 6.66

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.94
  • Number of Estimates 4
  • High Estimate -0.86
  • Low Estimate -0.98
  • Prior Year -1.12
  • Growth Rate Est. (year over year) +16.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.37 +40.08%
on 01/06/20
23.43 -8.11%
on 01/16/20
+5.23 (+32.05%)
since 12/27/19
3-Month
14.80 +45.47%
on 11/06/19
23.43 -8.11%
on 01/16/20
+6.15 (+39.99%)
since 10/25/19
52-Week
9.88 +117.91%
on 08/28/19
23.43 -8.11%
on 01/16/20
+4.26 (+24.67%)
since 01/25/19

Most Recent Stories

More News
Revance Therapeu Has Returned 16.4% Since SmarTrend Recommendation (RVNC)

SmarTrend identified an Uptrend for Revance Therapeu (NASDAQ:RVNC) on January 10th, 2020 at $18.55. In approximately 2 weeks, Revance Therapeu has returned 16.39% as of today's recent price of $21.59....

RVNC : 21.53 (-1.15%)
Will Revance Therapeutics Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor in Revance Therapeutics.

RVNC : 21.53 (-1.15%)
Look for Shares of Revance Therapeu to Potentially Pullback after Yesterday's 11.56% Rise

Revance Therapeu (NASDAQ:RVNC) traded in a range yesterday that spanned from a low of $17.34 to a high of $18.56. Yesterday, the shares gained 11.6%, which took the trading range above the 3-day high...

RVNC : 21.53 (-1.15%)
Revance Announces Transformative Aesthetics Portfolio Transaction with Exclusive U.S. Distribution Agreement of FDA-Approved Dermal Fillers from TEOXANE SA

--- Revance gains access to the growing $1.1B U.S. filler market with three differentiated products, and plans to launch in second quarter 2020 -

RVNC : 21.53 (-1.15%)
Revance to Participate in the 38th Annual J.P. Morgan Healthcare Conference

Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company pioneering new innovations in neuromodulator products for aesthetic and therapeutic indications, today announced that the company will...

JPM : 132.03 (-0.84%)
RVNC : 21.53 (-1.15%)
Revance Provides Corporate Update and Anticipated Milestones for 2020

Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company pioneering new innovations in neuromodulator products for aesthetic and therapeutic indications, today provided a corporate and product...

RVNC : 21.53 (-1.15%)
SmarTrend Watching for Potential Rebound in Shares of Revance Therapeu After 1.07% Loss

Revance Therapeu (NASDAQ:RVNC) traded in a range yesterday that spanned from a low of $16.16 to a high of $16.49. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of...

RVNC : 21.53 (-1.15%)
Facial Injectors Market Impressive Growth by 2029 | Allergan plc, GALDERMA INDIA Pvt. Ltd, Revance Therapeutics

“A Precise market analysis on Global | Know Up Trends And More About Industry Tycoons, Emerging Growth Factors, Opportunities, Top Key Players, Target Audience, Capital Investment Status, Production,...

AGN : 189.00 (+0.43%)
MKKGY : 26.0300 (-1.74%)
RVNC : 21.53 (-1.15%)
VRX.TO : 30.80 (-3.33%)
Revance Announces Publication of Pooled Results from Phase 3 Trials for Glabellar Lines in the Journal of the American Academy of Dermatology

Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company pioneering new innovations in neuromodulator products for aesthetic and therapeutic indications, today announced the publication of the...

RVNC : 21.53 (-1.15%)
Revance Announces Pricing of Public Offering of Common Stock

Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company developing next-generation neuromodulators for use in treating aesthetic and therapeutic conditions ("Revance" or the "Company"), today...

RVNC : 21.53 (-1.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade RVNC with:

Business Summary

Revance is a Silicon Valley-based biotechnology company. The company is developing a portfolio of products for aesthetic medicine and underserved therapeutic specialties, including dermatology and neurology. Revance's science is based upon a proprietary TransMTS' peptide technology, which when combined...

See More

Key Turning Points

2nd Resistance Point 22.21
1st Resistance Point 21.87
Last Price 21.53
1st Support Level 21.16
2nd Support Level 20.79

See More

52-Week High 23.43
Last Price 21.53
Fibonacci 61.8% 18.25
Fibonacci 50% 16.65
Fibonacci 38.2% 15.06
52-Week Low 9.88

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar